StonvexLoading…
StonvexCore line items from CRNC's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-08-04 | Q1 2026 2026-03-31 | Q4 2025 2025-12-31 | Annual 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $71.40M | $179.27M | $115.08M | $251.78M | $191.14M |
Operating Income | Not available | $26.87M | $29.31M | $-2.29M | $-529.00K |
Net Income | Not available | $-3.57M | $-5.24M | $-18.71M | $-5.35M |
EPS (Diluted) | $0.22 | $-0.08 | $-0.12 | $-0.43 | $-0.12 |
Total Assets | Not available | $616.95M | $602.04M | $630.59M | $636.80M |
Total Liabilities | Not available | $458.41M | $451.60M | $479.92M | $481.13M |
Cash & Equivalents | Not available | Not available | Not available | Not available | Not available |
Free Cash Flow OCF − CapEx | Not available | $49.27M | $35.65M | $46.82M | $37.07M |
Shares Outstanding | Not available | 45.17M | 45.02M | 43.37M | 43.26M |